Metralindole
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by KoIobok (talk | contribs) at 01:19, 8 December 2021 (Added Category:Tryptamines). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
![]() | |
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII |
|
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H17N3O |
Molar mass | 255.321 g·mol−1 |
3D model (JSmol) | |
|
Metralindole (Inkazan) is a reversible inhibitor of monoamine oxidase A (RIMA) which was investigated in Russia as a potential antidepressant.[1] It is structurally and pharmacologically related to pirlindole.
See also
References
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
![]() | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- CS1 Russian-language sources (ru)
- Drugs with non-standard legal status
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Multiple chemicals in Infobox drug
- Chemicals using indexlabels
- Chemical articles with multiple CAS registry numbers
- Articles containing unverified chemical infoboxes
- All stub articles